GRDN

Guardian Pharmacy Services Inc. Class A Common Stock (GRDN)

Stock · NYSE · Consumer Staples

$39.47as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 12, 2026

Guardian Pharmacy Services Q2 2026 Earnings Call Highlights. Guardian Pharmacy Services held its Q2 2026 earnings conference call, reviewing the quarter’s financial results and outlook. Management addressed performance metrics and future expectations, offering insight for investors. The discussion comes as the stock trades near its recent support level of $40.33, with an RSI around 40, indicating modest momentum.

Price chart

Open in TradingView

Active signals

Support Reject88.7%200 SMA Touch0.0%
Resistance level
$40.33
Industry
Retail-Drug Stores and Proprietary Stores

GRDN Signal Track Record

How signals performed across all stocks →

What GRDN's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike9-1.9%44%
Bollinger Band Breakout8-0.9%50%
Bollinger Band Breakdown4+19.1%100%
Any 20-session window (baseline)+4.1%64%

Computed by MarketWall from daily closing prices since July 16, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About GRDN

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and grou…

Sector
Consumer Staples
Industry
Retail-Drug Stores and Proprietary Stores
Employees
3,600

Fundamentals

1-day range
$39.26$41.22
Market cap
$2.50B
P/E (trailing)
38.13
P/E (forward)
27.67
EPS (trailing)
$1.02
Dividend yield
—
Beta
0.44
Avg. volume
489.4K
52-week range
$23.37$48.33
Next earnings: November 9, 2026 · EPS estimate $0.31confirmed

How Guardian Pharmacy Services Inc. Class A Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$1.45BNet Income$49.22M (3%)Cost of Revenue$1.16B (80%)SG&A$220.02M (15%)Tax$24.46M (2%)GRDN

Source: 10-K filed Mar 11, 2026 · via SEC EDGAR / Finnhub

Gross Profit$292.72M(20%)
Operating Income$72.70M(5%)

Forecasts

7 analyst ratings

Buy 92%
Hold 8%
Sell 0%
1-year price forecast
High
$52
+31.7%
Median
$50
+26.7%
Low
$47
+19.1%

Guardian Pharmacy Services Inc. Class A Common Stock Competitors

Chosen by industry and closest market cap.

  • GRDN
    Guardian Pharmacy Services Inc. Class A Common Stock
    $39.47
    ▼ 0.53%
    Market cap $2.50BP/E 38.13
    $23.37$48.33
  • PETS
    PetMed Express Inc. Common Stock
    $1.18
    ▼ 3.28%
    Market cap $42.10MP/E —
    $1.26$4.1
  • YI
    111 Inc. American Depositary Shares
    $3.13
    ▲ 1.29%
    Market cap $33.34MP/E —
    $2.48$11.17
  • RDGT
    Ridgetech Inc. Ordinary Shares
    $0.84
    ▲ 1.20%
    Market cap $2.85MP/E 0.24
    $0.67$760.5
  • CVS
    CVS Health Corporation Common Stock
    $92.36
    ▼ 0.24%
    Market cap $122.77BP/E 23.91
    $69.51$110.68

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
24.36M
Disposed
0

Institutional Ownership

March 31, 2026

Total shares held
27.72M
Total value held
$988.68M
Institutional holders
162
Top holders this quarter
  • Unknown2.36M
  • Unknown1.77M
  • Unknown1.76M
  • Unknown1.31M
  • Unknown1.26M
  • Unknown1.23M
  • Unknown1.19M
  • Unknown1.08M
  • Unknown1.03M
  • Unknown1.02M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.